Provided By GlobeNewswire
Last update: Aug 11, 2025
Achieves Positive Net Income in the Second Quarter and Positive Adjusted EBITDA1 for the Second Quarter and Six Months Ended June 30, 2025
ENGLEWOOD, Colo., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”), a leading developer of cost-effective, renewable hydrocarbon fuels and chemicals that also can deliver significant carbon emission abatement, today announced financial results for the second quarter and six months ended June 30, 2025. In a landmark milestone, the Company reported positive net income for the second quarter of 2025 and that it achieved the previously announced positive Adjusted EBITDA1 target for the second quarter and six months ended June 30, 2025, as a result of successful performance of our assets.
Net Income Attributable to Gevo Grew by $20 Million and Adjusted EBITDA1 Grew by $32 Million During the Six Months Ended June 30, 2025, Compared to Same Period Last Year
The key growth drivers were:
Other Recent Transactions:
In May, we entered into a definitive agreement to sell our subsidiary Agri-Energy, LLC to A.E. Innovation, LLC (“A.E.”) for $7 million. The transaction includes Agri’s 18-million-gallon-per-year ethanol-production facility located in Luverne, Minnesota and is expected to close by the end of 2025, subject to the procurement of financing by A.E. and the satisfaction of other customary closing conditions. Following the sale, we will retain the ownership of certain equipment at the facility, including isobutanol fermentation capacity and some of the vacant land.
Additionally, after the second quarter, we closed on a refinancing in July related to GevoRNG, resulting in the release of approximately $30 million of restricted cash on our balance sheet after reserves and transaction costs.
Our Renewable Jet Fuel Platform Positions Gevo For Long-Term, Reproducible Growth.
2025 Second Quarter Financial Highlights
Management Comment
“This was a landmark quarter for us,” commented Dr. Patrick Gruber, Gevo’s Chief Executive Officer. “Our results are delivering on the targets we said we would achieve this year, even sooner than we expected. We said we would grow recurring Adjusted EBITDA, and it has begun—real cash flow, not one-time, not speculative. It’s coming from running our GevoND operations efficiently, capturing carbon, and selling voluntary carbon credits as CDRs and CFPCs, in addition to ethanol, protein, corn oil, and RNG sales. All of this sets the stage for growth of SAF production, more liquid fuel production, more CDRs and more CFPCs.”
“I really like these results regarding carbon sales. It’s outstanding that companies are willing to step up and pay for what they believe in--carbon reduction. It’s a new product; and for us, it’s a co-product. Our fuel manufacturing systems are designed end-to-end to abate carbon. The result is that we can manufacture cost-competitive renewable liquid fuels, while abating carbon. What I like about our plans for growth even more is the potential for rural economic growth, the additional production of protein and feed for the food chain, and the potential increased profit for the farmers who supply us. It’s good for America and for Gevo,” continued Dr. Gruber.
Dr. Gruber added: “Building on this base of profitability and our extensive history with SAF, we are positioning ourselves for future reproducible growth. We’re engineering ATJ-30, getting ready for ATJ-60, which needs to be financed, and setting ourselves up to develop this system in the U.S. and globally. The world is going to need more jet fuel. Collectively we believe the path ahead is to make jet fuel from renewables that abate the carbon footprint, which can compete on a cost basis with petro-jet fuel. We believe Gevo is positioned to meet the growing world demand for jet fuel with SAF. That’s the vision. SAF done right is a cost-effective, scalable platform for fulfilling growing jet fuel demand, supporting agriculture for future generations, and building real American energy independence.”
Leke Agiri, Gevo’s Chief Financial Officer, commented: “We achieved positive net income and positive Adjusted EBITDA in the second quarter, marking a major financial milestone and delivering on what we said we would do. This reflects the tangible value created by our GevoND and GevoRNG business segments, along with the monetization of the CFPC.”
Mr. Agiri continued: “Our CFPC production is booked each quarter as a reduction in COGS as we produce and earn this credit. In addition, our sales of these credits have been backed by a tax insurance policy to mitigate residual risk associated with transferring these credits to buyers, which we view as low risk to begin with. In short, the growth we have reported this quarter represents a step-change for us.”
Further Details on the Clean Fuel Production Credit
Also known as the Section 45Z tax credit, the CFPC was an extension of previous domestic biofuel incentives and took effect in 2025 as part of the Inflation Reduction Act. It was subsequently extended further in the One Big Beautiful Bill Act, through 2029. Historically, similar credits called the Blenders Tax Credit have been extended by legislation to continue to promote U.S. domestic agriculture and biofuel production. As disclosed in our Current Report on Form 8-K filed on July 7, 2025, we initially sold $22 million of these generated credits to a bank. This bank has a right of first offer (subject to certain conditions) to purchase substantially all of the remaining credits we expect to generate in 2025. In addition, the market demand for similar investment and production tax credits is approximately $30 billion4 according to third party research of this market, and we expect to sell the full amount of our capacity each year.
2025 Second Quarter Financial Results
Operating revenue. During the three months ended June 30, 2025, operating revenue increased by $38.2 million compared to the three months ended June 30, 2024. This increase was primarily due to $37.2 million in revenue from GevoND, and $0.9 million in revenue from the sale of isooctane and others.
Cost of production. Cost of production increased $13.8 million during the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to production costs related to GevoND operation, partially offset by $20.8 million 45Z tax credit booked, net of transaction costs. The 45Z tax credit, designed to incentivize the production of SAF, allowed us to lower overall production costs, while maintaining production levels.
Depreciation and amortization. Depreciation and amortization increased $2.9 million during the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to $4.8 million depreciation related to GevoND, partially offset by a $2.5 million reduction of depreciation related to assets fully depreciated at our Luverne, Minnesota facility.
Research and development expense. Research and development expenses decreased $0.7 million during the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to decreased consulting expenses.
General and administrative expense. General and administrative expense decreased $0.7 million during the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to a $1.9 million decrease in stock-based compensation, partially offset by $1.2 million higher insurance costs, professional and consulting services and computer and software costs.
Project development costs. Project development costs are primarily related to our Alcohol-to-Jet Projects and Verity, which consist primarily of employee expenses, preliminary engineering costs, and technical consulting fees. Project development costs decreased $6.9 million during the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to a $3.3 million decrease in consulting and professional services fees, as well as the timing of $3.5 million reimbursement received from the USDA program during the second quarter.
Income (loss) from operations. The Company’s loss from operations decreased by $29.8 million for the three months ended June 30, 2025, compared to the same period in 2024. This improvement was primarily driven by increased revenues from GevoND, lower cost of production due to the recognition of the 45Z tax credit, a reduction in project development expenses, and decreased general and administrative expenses.
Interest expense. Interest expense increased $3.2 million during the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to the debt used to acquire GevoND and a higher interest rate on our remarketed RNG bonds.
Interest and investment income. Interest and investment income decreased $2.8 million during the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to the acquisition of GevoND and to fund our capital projects and operating costs, resulting in a lower balance of cash equivalent investments during the three months ended June 30, 2025.
Webcast and Conference Call Information
Hosting today’s conference call at 4:30 p.m. ET will be Dr. Patrick R. Gruber, Chief Executive Officer, Dr. Chris Ryan, President and Chief Operating Officer, Leke Agiri, Chief Financial Officer, Dr. Paul Bloom, Chief Business Officer and Dr. Eric Frey, Vice President of Finance and Strategy. They will review Gevo’s financial results and provide an update on recent corporate highlights.
To participate in the live call, please register through the following event weblink: https://register-conf.media-server.com/register/BI837becc646fa4780899cbd8ed1b21b9a. After registering, participants will be provided with a dial-in number and pin.
To listen to the conference call (audio only), please register through the following event weblink: https://edge.media-server.com/mmc/p/u9fuak7q/.
A webcast replay will be available two hours after the conference call ends on August 11, 2025. The archived webcast will be available in the Investor Relations section of Gevo’s website at www.gevo.com.
About Gevo
Gevo is a next-generation diversified energy company committed to fueling America’s future with cost-effective, drop-in fuels that contribute to energy security, abate carbon, and strengthen rural communities to drive economic growth. Gevo’s innovative technology can be used to make a variety of renewable products, including SAF, motor fuels, chemicals, and other materials that provide U.S.-made solutions. By investing in the backbone of rural America, Gevo’s business model includes developing, financing, and operating production facilities that create jobs and revitalize communities. Gevo owns and operates one of the largest dairy-based RNG facilities in the United States, turning by-products into clean, reliable energy. We also operate an ethanol plant with an adjacent CCS facility, further solidifying America’s leadership in energy innovation. Additionally, Gevo owns the world’s first production facility for specialty ATJ fuels and chemicals. Gevo’s market-driven “pay for performance” approach regarding carbon and other sustainability attributes, helps ensure value is delivered to our local economy. Through its Verity subsidiary, Gevo provides transparency, accountability, and efficiency in tracking, measuring and verifying various attributes throughout the supply chain. By strengthening rural economies, Gevo is working to secure a self-sufficient future and to make sure value is brought to the market.
For more information, see www.gevo.com.
Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, including, without limitation, future CDR sales and growth, the CDR market, our CCS capacity, future CFPC credit generation and sales, jet fuel market growth, the financing and the timing of our ATJ-60 project, our ATJ-30 project, our financial condition, our results of operation and liquidity, our business plans, our business development activities, financial projections related to our business, our RNG business, our plans to develop our business, our ability to successfully develop, construct, and finance our operations and growth projects, our ability to achieve cash flow from our planned projects, and other statements that are not purely statements of historical fact. These forward-looking statements are made based on the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in our most recent Annual Report on Form 10-K and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.
Non-GAAP Financial Information
This press release contains a financial measure that does not comply with U.S. generally accepted accounting principles (“GAAP”), including non-GAAP adjusted EBITDA. Non-GAAP adjusted EBITDA excludes depreciation and amortization, allocated intercompany expenses for shared service functions, and non-cash stock-based compensation from GAAP loss from operations. Management believes this measure is useful to supplement its GAAP financial statements with this non-GAAP information because management uses such information internally for its operating, budgeting and financial planning purposes. This non-GAAP financial measure also facilitates management’s internal comparisons to Gevo’s historical performance as well as comparisons to the operating results of other companies. In addition, Gevo believes this non-GAAP financial measure is useful to investors because it allows for greater transparency into the indicators used by management as a basis for its financial and operational decision making. Non-GAAP information is not prepared under a comprehensive set of accounting rules and therefore, should only be read in conjunction with financial information reported under U.S. GAAP when understanding Gevo’s operating performance. A reconciliation between GAAP and non-GAAP financial information is provided below.
Gevo, Inc.
Condensed Consolidated Balance Sheets
(In thousands, except share and per share amounts)
June 30, 2025 | December 31, 2024 | ||||||
Assets | |||||||
Current assets | |||||||
Cash and cash equivalents | $ | 57,257 | $ | 189,389 | |||
Restricted cash | 69,644 | 1,489 | |||||
Trade accounts receivable, net | 11,025 | 2,411 | |||||
Inventories | 16,939 | 4,502 | |||||
Prepaid expenses and other current assets | 15,576 | 5,920 | |||||
Total current assets | 170,441 | 203,711 | |||||
Property, plant and equipment, net | 344,914 | 221,642 | |||||
Restricted cash | — | 68,155 | |||||
Operating right-of-use assets | 2,137 | 1,064 | |||||
Finance right-of-use assets | 1,201 | 1,877 | |||||
Intangible assets, net | 70,327 | 8,129 | |||||
Goodwill | 43,558 | 3,740 | |||||
Deposits and other assets | 69,539 | 75,623 | |||||
Total assets | $ | 702,117 | $ | 583,941 | |||
Liabilities | |||||||
Current liabilities | |||||||
Accounts payable and accrued liabilities | $ | 43,450 | $ | 22,006 | |||
Operating lease liabilities | 677 | 333 | |||||
Finance lease liabilities | 1,211 | 2,001 | |||||
Remarketed Bonds payable, net | 27,895 | 21 | |||||
Total current liabilities | 73,233 | 24,361 | |||||
Remarketed Bonds payable, net | 39,631 | 67,109 | |||||
Loans payable | 99,966 | — | |||||
Operating lease liabilities | 1,703 | 966 | |||||
Finance lease liabilities | 234 | 187 | |||||
Asset retirement obligation | 2,177 | — | |||||
Other long-term liabilities | 5,405 | 1,830 | |||||
Total liabilities | 222,349 | 94,453 | |||||
Redeemable non-controlling interest | 5,664 | — | |||||
Equity | |||||||
Common stock, $0.01 par value per share; 500,000,000 shares authorized; 241,841,590 and 239,176,293 shares issued and outstanding at June 30, 2025, and December 31, 2024, respectively. | 2,419 | 2,392 | |||||
Additional paid-in capital | 1,291,630 | 1,287,333 | |||||
Accumulated deficit | (819,945 | ) | (800,237 | ) | |||
Total stockholders' equity | 474,104 | 489,488 | |||||
Total liabilities and stockholders' equity | $ | 702,117 | $ | 583,941 | |||
Gevo, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2025 |
2024 |
2025 |
2024 |
||||||||||||
Total operating revenues | $ | 43,413 | $ | 5,260 | $ | 72,522 | $ | 9,250 | |||||||
Operating expenses: | |||||||||||||||
Cost of production | 17,265 | 3,423 | 38,711 | 6,010 | |||||||||||
Depreciation and amortization | 7,213 | 4,277 | 12,835 | 8,728 | |||||||||||
Research and development expense | 934 | 1,641 | 1,986 | 3,189 | |||||||||||
General and administrative expense | 10,783 | 11,513 | 21,867 | 23,663 | |||||||||||
Project development costs | 831 | 7,736 | 5,833 | 13,055 | |||||||||||
Acquisition related costs | — | — | 4,438 | — | |||||||||||
Facility idling costs | 591 | 699 | 1,195 | 1,775 | |||||||||||
Total operating expenses | 37,617 | 29,289 | 86,865 | 56,420 | |||||||||||
Income (loss) from operations | 5,796 | (24,029 | ) | (14,343 | ) | (47,170 | ) | ||||||||
Other (expense) income | |||||||||||||||
Interest expense | (4,345 | ) | (1,113 | ) | (7,639 | ) | (1,655 | ) | |||||||
Interest and investment income | 1,322 | 4,143 | 3,092 | 8,736 | |||||||||||
Other (expense) income, net | (44 | ) | (3 | ) | (154 | ) | 212 | ||||||||
Total other (expense) income, net | (3,067 | ) | 3,027 | (4,701 | ) | 7,293 | |||||||||
Net income (loss) | 2,729 | (21,002 | ) | (19,044 | ) | (39,877 | ) | ||||||||
Net income attributable to redeemable non-controlling interest | 585 | — | 540 | — | |||||||||||
Net income (loss) attributable to Gevo, Inc. | $ | 2,144 | $ | (21,002 | ) | $ | (19,584 | ) | $ | (39,877 | ) | ||||
Net income (loss) per share - basic | $ | 0.01 | $ | (0.09 | ) | $ | (0.08 | ) | $ | (0.17 | ) | ||||
Net income (loss) per share - diluted | $ | 0.01 | $ | (0.09 | ) | $ | (0.08 | ) | $ | (0.17 | ) | ||||
Weighted-average common shares outstanding - basic | 232,945,048 | 239,014,435 | 232,490,122 | 239,929,385 | |||||||||||
Weighted-average common shares outstanding - diluted | 236,839,117 | 239,014,435 | 232,490,122 | 239,929,385 | |||||||||||
Gevo, Inc.
Condensed Consolidated Statements of Stockholders’ Equity
(In thousands, except share amounts)
For the Six Months Ended June 30, 2025 and 2024 | |||||||||||||||||||||
Stockholders' Equity | Mezzanine Equity | ||||||||||||||||||||
Common Stock | |||||||||||||||||||||
Shares | Amount | Paid-In Capital | Accumulated Deficit |
Stockholders’ Equity |
Redeemable Non-Controlling Interest |
||||||||||||||||
Balance, December 31, 2024 | 239,176,293 | $ | 2,392 | $ | 1,287,333 | $ | (800,237 | ) | $ | 489,488 | $ | — | |||||||||
Issuance of redeemable non-controlling interest | — | — | — | — | — | 5,000 | |||||||||||||||
Non-cash stock-based compensation | — | — | 4,142 | — | 4,142 | — | |||||||||||||||
Stock-based awards and related share issuances, net | 2,665,297 | 27 | 155 | — | 182 | — | |||||||||||||||
Change in redemption value of redeemable non-controlling interest | — | — | — | (124 | ) | (124 | ) | 124 | |||||||||||||
Net loss | — | — | — | (19,584 | ) | (19,584 | ) | 540 | |||||||||||||
Balance, June 30, 2025 | 241,841,590 | $ | 2,419 | $ | 1,291,630 | $ | (819,945 | ) | $ | 474,104 | $ | 5,664 | |||||||||
Balance, December 31, 2023 | 240,499,833 | $ | 2,405 | $ | 1,276,581 | $ | (721,597 | ) | $ | 557,389 | — | ||||||||||
Non-cash stock-based compensation | — | — | 8,699 | — | 8,699 | — | |||||||||||||||
Stock-based awards and related share issuances, net | 6,160,920 | 62 | 533 | — | 595 | — | |||||||||||||||
Repurchase of common stock | (6,095,513 | ) | (61 | ) | (4,003 | ) | — | (4,064 | ) | — | |||||||||||
Net loss | — | — | — | (39,877 | ) | (39,877 | ) | — | |||||||||||||
Balance, June 30, 2024 | 240,565,240 | $ | 2,406 | $ | 1,281,810 | $ | (761,474 | ) | $ | 522,742 | $ | — | |||||||||
Gevo, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
Six Months Ended June 30, | |||||||
2025 | 2024 | ||||||
Operating Activities | |||||||
Net loss | $ | (19,044 | ) | $ | (39,877 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Stock-based compensation | 4,142 | 8,699 | |||||
Depreciation and amortization | 12,835 | 8,728 | |||||
Change in fair value of derivative instruments | (652 | ) | — | ||||
Tax credit generation | (21,494 | ) | — | ||||
Other non-cash income | 1,274 | 1,276 | |||||
Changes in operating assets and liabilities, net of effects of acquisition: | |||||||
Accounts receivable | (3,634 | ) | 341 | ||||
Inventories | (788 | ) | 243 | ||||
Prepaid expenses and other current assets, deposits and other assets | (9,504 | ) | (5,941 | ) | |||
Accounts payable, accrued expenses and non-current liabilities | 10,295 | (989 | ) | ||||
Net cash used in operating activities | (26,570 | ) | (27,520 | ) | |||
Investing Activities | |||||||
Acquisitions of property, plant and equipment | (11,077 | ) | (26,708 | ) | |||
Acquisition of Red Trail Energy | (198,461 | ) | — | ||||
Net cash used in investing activities | (209,538 | ) | (26,708 | ) | |||
Financing Activities | |||||||
Loan proceeds | 105,000 | — | |||||
Payment of debt issuance costs | (5,480 | ) | (1,665 | ) | |||
Non-controlling interest | 5,000 | — | |||||
Proceeds from the exercise of stock options | 182 | — | |||||
Payment of loans payable | — | (65 | ) | ||||
Payment of finance lease liabilities | (726 | ) | (255 | ) | |||
Repurchases of common stock | — | (4,064 | ) | ||||
Net cash provided by (used in) financing activities | 103,976 | (6,049 | ) | ||||
Net decrease in cash and cash equivalents | (132,132 | ) | (60,277 | ) | |||
Cash, cash equivalents and restricted cash at beginning of period | 259,033 | 375,597 | |||||
Cash, cash equivalents and restricted cash at end of period | $ | 126,901 | $ | 315,320 | |||
Gevo, Inc.
Reconciliation of GAAP to Non-GAAP Financial Information
(In thousands)
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||
2025 | 2024 |
2025 |
2024 |
|||||||||||
Non-GAAP Adjusted EBITDA (Consolidated): | ||||||||||||||
Income (loss) from operations | $ | 5,796 | $ | (24,029 | ) | $ | (14,343 | ) | $ | (47,170 | ) | |||
Depreciation and amortization | 7,213 | 4,277 | 12,835 | 8,728 | ||||||||||
Stock-based compensation | 2,244 | 4,466 | 4,142 | 8,699 | ||||||||||
Change in fair value of derivative instruments | 2,080 | — | (652 | ) | — | |||||||||
Non-GAAP adjusted EBITDA (loss) (Consolidated) | $ | 17,333 | $ | (15,286 | ) | $ | 1,982 | $ | (29,743 | ) | ||||
Three Months Ended June 30, 2025 | |||||||||||||||||
Gevo | GevoFuels | GevoRNG | GevoND | Consolidated | |||||||||||||
Non-GAAP Adjusted EBITDA (Consolidated): | |||||||||||||||||
Income (loss) from operations | $ | (12,366 | ) | $ | (376 | ) | $ | 1,456 | $ | 17,082 | $ | 5,796 | |||||
Depreciation and amortization | 779 | — | 1,374 | 5,060 | 7,213 | ||||||||||||
Allocated intercompany expenses for shared service functions | 259 | — | (259 | ) | — | — | |||||||||||
Stock-based compensation | 2,230 | — | 12 | 2 | 2,244 | ||||||||||||
Change in fair value of derivative instruments | — | — | — | 2,080 | 2,080 | ||||||||||||
Non-GAAP adjusted EBITDA (loss) (Consolidated) | $ | (9,098 | ) | $ | (376 | ) | $ | 2,583 | $ | 24,224 | $ | 17,333 | |||||
Six Months Ended June 30, 2025 | |||||||||||||||||||
Gevo | GevoFuels | GevoRNG | GevoND | Consolidated | |||||||||||||||
Non-GAAP Adjusted EBITDA (Consolidated): | |||||||||||||||||||
Income (loss) from operations | $ | (33,350 | ) | $ | (1,100 | ) | $ | 1,925 | $ | 18,182 | $ | (14,343 | ) | ||||||
Depreciation and amortization | 1,526 | — | 2,777 | 8,532 | 12,835 | ||||||||||||||
Allocated intercompany expenses for shared service functions | (631 | ) | — | 631 | — | — | |||||||||||||
Stock-based compensation | 4,167 | — | (27 | ) | 2 | 4,142 | |||||||||||||
Change in fair value of derivative instruments | — | — | — | (652 | ) | (652 | ) | ||||||||||||
Non-GAAP adjusted EBITDA (loss) (Consolidated) | $ | (28,288 | ) | $ | (1,100 | ) | $ | 5,306 | $ | 26,064 | $ | 1,982 | |||||||
Three Months Ended June 30, 2024 | |||||||||||||||
Gevo | GevoFuels | GevoRNG | Consolidated | ||||||||||||
Non-GAAP Adjusted EBITDA (Consolidated): | |||||||||||||||
Loss from operations | $ | (20,597 | ) | $ | (1,224 | ) | $ | (2,208 | ) | $ | (24,029 | ) | |||
Depreciation and amortization | 2,976 | — | 1,301 | 4,277 | |||||||||||
Allocated intercompany expenses for shared service functions | (891 | ) | — | 891 | — | ||||||||||
Stock-based compensation | 4,423 | — | 43 | 4,466 | |||||||||||
Non-GAAP adjusted EBITDA (loss) (Consolidated) | $ | (14,089 | ) | $ | (1,224 | ) | $ | 27 | $ | (15,286 | ) | ||||
Six Months Ended June 30, 2024 | |||||||||||||||
Gevo | GevoFuels | GevoRNG | Consolidated | ||||||||||||
Non-GAAP Adjusted EBITDA (Consolidated): | |||||||||||||||
Loss from operations | $ | (40,723 | ) | $ | (2,234 | ) | $ | (4,213 | ) | $ | (47,170 | ) | |||
Depreciation and amortization | 6,053 | — | 2,675 | 8,728 | |||||||||||
Allocated intercompany expenses for shared service functions | (1,781 | ) | — | 1,781 | — | ||||||||||
Stock-based compensation | 8,622 | — | 77 | 8,699 | |||||||||||
Non-GAAP adjusted EBITDA (loss) (Consolidated) | $ | (27,829 | ) | $ | (2,234 | ) | $ | 320 | $ | (29,743 | ) | ||||
Media Contact
Heather Manuel
Vice President of Stakeholder Engagement & Partnerships
PR@gevo.com
Investor Contact
Eric Frey, PhD
Vice President of Finance and Strategy
IR@Gevo.com
___________________________
1 Adjusted EBITDA is a non-GAAP measure calculated by adding back depreciation and amortization, allocated intercompany expenses for shared service functions, non-cash stock-based compensation, and the change in fair value of derivative instruments to GAAP loss from operations as well as monetized tax credits, if any. A reconciliation of adjusted EBITDA to GAAP loss from operations is provided in the financial statement tables following this release. Adjusted EBITDA was referred to as “cash EBITDA” in previous periods. See Non-GAAP Financial Information below.
2 Source: https://www.cdr.fyi/
3 Source: US EIA Annual Energy Outlook, April 2025.
4 Source: https://www.cruxclimate.com/insights/2024-transferable-tax-credit-market-key-takeaways
1.99
+0.74 (+59.2%)
Find more stocks in the Stock Screener